:loudspeaker: Upcoming Scheduled Maintenance

Please be advised that this application will be unavailable due to scheduled maintenance from June 18, 2026 at 5:00 PM ET through June 21, 2026. During this time, users will not be able to access the system. Please plan your work accordingly. We apologize for any inconvenience and appreciate your patience.

U.S. Department of Health and Human Services

National Institutes of Health

National Center for Advancing Translational Sciences

Subscribe

This article provides an overview of the application process for FDA incentive programs that facilitate orphan drug development. Orphan Drug and Rare Pediatric Disease Designation requirements, examples, and relevant resources are shared.

Human Gene Therapy | March 20, 2023